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Abstract 
 
Background: The need for skilled pre-travel health practitioners increases as the number of 
travelers at risk for travel-related illness rises. Few publications describe the role of pharmacists 
as travel medicine clinicians. Pre-travel medication and vaccination recommendations and 
receipt were compared between primary care providers without special training and clinical 
pharmacists specializing in pre-travel health. 
Methods: This was a retrospective chart review comparison of patients seen for pre-travel health 
services in a pharmacist-run travel clinic (PTC) and by primary care providers (PCP) in 2007 at a 
university student health center. Vaccine and medication recommendations were assessed for 
consistency with national and international guidelines. Medical and pharmacy records were 
queried to determine receipt of vaccines and medications. 
Results: The 341 patients seen in PTC were more often recommended antibiotics for travelers’ 
diarrhea when indicated (96% vs. 50%, P < 0.0001) than the 172 seen by the PCPs and were also 
more likely to receive their medication (75% vs. 63%, P = 0.04). Those seen by a PCP were 
more frequently prescribed antibiotics for travelers’ diarrhea that were not consistent with 
guidelines (not ordered when indicated 49% vs 6%, P < 0.0001 and ordered when not indicated 
21% vs. 3%, P < 0.0001). Patients seen in the PTC were more often prescribed antimalarials 
when indicated (98% vs. 81%, P < 0.0001), and those seen by a PCP were more frequently 
prescribed antimalarials that were not consistent with guidelines (not ordered when indicated 
15% vs 1%, P < 0.0001 and ordered when not indicated 19% vs. 2%, P < 0.0001). Patients seen 
in the PTC were ordered more vaccines per patient when indicated (mean = 2.77 vs 2.31, P = 
0.0012), and were also more likely to receive more vaccines when ordered (mean = 2.38 vs. 1.95, 
P = 0.0039). The PCPs recommended more vaccines that were not consistent with guidelines per 
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patient (not ordered when indicated: mean = 0.78 vs 0.12, P < 0.0001, ordered when not 
indicated: mean 0.18 vs. 0.025, P < 0.0001). 
Conclusions: A pharmacist-run pre-travel health clinic can provide consistent evidence-based 
care and improve patient compliance compared to primary care providers without special 
training.  Pre-travel health is a dynamic and specialized field that requires adequate time, 
resources, and expertise to deliver the best possible care.  
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Background 
Over the past few decades, the number of international tourists has grown from 457 
million in 1990 to 880 million in 2009, and is estimated to reach 1.6 billion by 2020, with an 
increasing proportion visiting the developing world. 1 Approximately 8 percent of travelers to the 
developing world will require medical care during or after travel 2, most often for vaccine 
preventable diseases and/or illnesses preventable by chemoprophylaxis and behavioral 
measures.3-4 With the rapidly increasing number of travelers at high risk for travel-related illness, 
there is an increased need for highly skilled travel medicine practitioners. 
Despite common misperceptions, a thorough pre-travel consultation encompasses much 
more than administration of vaccines. It is a comprehensive session that includes risk assessment 
of travelers on their personal risk for travel-related illnesses; recommendation of non-
prescription products and travel-related equipment; counseling on behavioral measures such as 
basic food/water and insect precautions; prescription medications; administration of routine, 
recommended, and required vaccinations; provision of written educational materials, and 
counseling on personal safety and security.5-11 Unfortunately, not all travelers seek or receive this 
type of comprehensive consultation prior to departure, as a result there is a significant lack of 
knowledge and perception of risk regarding travel-related health issues among travelers 
themselves.12-16  
 A 2003 New York airport survey serves as an example. In this study most travelers 
surveyed were going to places where Hepatitis A was a risk, but only 14% had received the 
vaccine. Furthermore, 27% of those who were going to high risk malaria regions thought they 
were not at risk, and only 46% had antimalarials with them. Of the travelers who had 
antimalarials, 42 % were carrying the medication chloroquine to areas with chloroquine-resistant 
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plasmodium falciparum. 14  Recently, the CDC reported that there were 508 U.S. civilians who 
acquired malaria abroad and for those whom chemoprophylaxis information was known (n=480), 
71% reported they did not take a chemoprophylactic regimen recommended by the CDC. 17 
While there is a deficiency in knowledge and compliance with recommendations among 
travelers, there is also a need for improvement in education and training among health care 
providers. 14-15, 18-23  Travel medicine is a dynamic specialty that necessitates advanced education 
and training, as well as keeping up-to-date with current geographic risks. 11, 24  Primary care 
providers are frequently called upon to provide pre-travel advice and recommendations, but may 
lack sufficient knowledge, training, and time to adequately provide such services. 13, 18, 21-22  In 
recent years, organizations such as the International Society of Travel Medicine and the 
American Society of Tropical Medicine and Hygiene have taken major steps to further education 
and training among health care providers and to advance travel medicine as a growing 
specialty.24 
 There are very few publications describing the role of pharmacists in travel medicine. 
Descriptive studies of clinical pharmacy travel medicine services exist, 25-27 and the few studies 
that have evaluated the quality of travel recommendations of pharmacists have focused on the 
community pharmacy setting. 28-31  To our knowledge, there are no published studies evaluating 
the pre-travel health care of primary care providers in a student health setting and no studies 
comparing the quality of the pre-travel recommendations of primary care providers without 
special training versus clinical pharmacists who specialize in pre-travel health. 
 The setting for this study is a student health center at a major university. The clinical 
pharmacists at the study setting operate a pre-travel health clinic at the Student Health Center, 
which serves roughly 30,000 students, and have prescriptive authority for vaccines and 
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medications under physician protocol. The objectives of this study are to compare the 
recommendations for travel-related medications and vaccinations of the primary care providers 
and the pharmacists specializing in pre-travel health, and also compare medication and 
vaccination compliance between the two groups. 
Methods 
 This was a retrospective comparison of all patients seen by a clinical pharmacist in a 
pharmacist-run travel clinic (PTC) or by a primary care provider (PCP) for international travel 
over a 1 year period in 2007 at a university student health center. The PCPs included physicians, 
physician assistants and nurse practitioners.  Data was obtained from an internal quality 
assurance study and included information regarding itinerary, pediatric and adult vaccination 
history, medical history, and recommendation and receipt of medications and vaccines during 
each visit. Study subjects were college students 18 years or older who self-referred for a travel 
consultation.  
 The PTC providers spent approximately 5 to 10 minutes per patient researching 
destination risks prior to the visit and had a practice limited solely to pre-travel health. In 
addition, the pharmacist providers had post-doctoral residency training that included travel 
medicine and all possessed the Certificate of Knowledge in Travel Health® (CTH®) from the 
International Society of Travel Medicine (ISTM). Visits in the pharmacist-run travel clinic are 
structured to include thorough verbal counseling, printed patient education as well as provision 
of necessary pre-travel medications and vaccines.  In comparison, none of the PCPs had a 
specialty practice or special training in travel medicine, nor were they required to complete such 
training for their clinical practice. Pharmacists and PCPs had access to the same travel medicine 
electronic resources. 
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 The decision to go to the PTC or a PCP was based on appointment availability and 
scheduling preference of the student, and both the PTC and the PCPs had 30 minute 
appointments. During the quality assurance process, vaccine and medication recommendations 
were assessed for consistency with recommendations and guidelines from the Centers for 
Disease Control and Prevention (CDC). Where CDC guidelines were unclear, the World Health 
Organization and Travax® Encompass (Shoreland, Inc.) were consulted as secondary sources. 
Medical and pharmacy records were queried to determine if students received recommended 
medications and vaccines prior to travel. Prescriptions and vaccinations that were documented as 
refused/declined by the patient were excluded from the analyses of receipt rates. All vaccines 
were administered by nurses in the immunization clinic and all medications were dispensed from 
the campus pharmacy. IRB approval was obtained prior to initiating the study. 
Basic characteristics of the travelers and the frequencies (or the average numbers) of the 
pre-travel recommendations between the PTC and the PCP groups were compared by using Chi-
square test (or Fisher’s exact test) for categorical variables, and two sample T-test or Wilcoxon-
Mann-Whitney Test (Non-parametric version of independent samples T-test) for continuous 
variables, if the normality assumptions underlying the T-test were violated. The primary 
outcomes for vaccines and medications were 1) indicated and ordered, 2) indicated and not 
ordered (excluding refused/declined), 3) not indicated and ordered, 4) and ordered and received 
(excluding refused/declined). The univariate and multivariate logistic regressions (results not 
shown in tables) were performed to help rate the findings according to their importance as 
risk/protective factors. All variables that showed the association with the pre-travel 
recommendations in the univariate models having P values below 0.10 were entered into the 
more comprehensive multiple logistic regression models, which included visit type (PTC or 
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PCP), trip duration, purposes of travel (for school activities and being volunteer), and destination 
(Southeast Asia). All statistical significance was assessed using an alpha level of 0.05. Statistical 
analysis was performed using SAS 9.2.+  
Results 
 In 2007, 513 travelers were identified, 172 were seen by a PCP and 341 were seen in the 
PTC. Travelers who were seen in the PTC were more often prescribed antibiotics for self-
treatment of travelers’ diarrhea when indicated (96% vs. 50%, P < 0.0001), while travelers seen 
by a PCP were more likely to be prescribed antibiotics not consistent with guidelines (not 
ordered when indicated 49% vs 6%, P < 0.0001 and ordered when not indicated 21% vs. 3%, P < 
0.0001) (Table 2). Furthermore, patients who were seen in the PTC were more likely to pick up 
their medication from the pharmacy than those who were prescribed antibiotics by a PCP (75% 
vs. 63%, P = 0.04). Travelers seen in the PTC were also more often prescribed antimalarials 
when indicated (98% vs. 81%, P < 0.0001), while those seen by a PCP were more frequently 
prescribed antimalarials not consistent with guidelines (not ordered when indicated 15% vs 1%, 
P < 0.0001 and ordered when not indicated 19% vs. 2%, P < 0.0001). There was no statistically 
significant difference in antimalarial pick-up rates from the pharmacy between the two groups 
(Table 2). 
 Results regarding the ordering and receipt of vaccines were similar to those of antibiotics 
and antimalarials. To account for multiple vaccines ordered at the same time, the number of 
vaccines per patient was calculated and used for comparison purposes.  Patients seen in the PTC 
were ordered more vaccines per patient when indicated (mean = 2.77 vs 2.31, P = 0.0012), and 
per patient were also more likely to receive vaccines when ordered (mean = 2.38 vs. 1.95, P = 
0.0039). The PCPs recommended more vaccines that were not consistent with guidelines per 
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patient (not ordered when indicated: mean = 0.78 vs 0.12, P < 0.0001, ordered when not 
indicated: mean 0.18 vs. 0.025, P < 0.0001 (Table 3). 
 In addition to differences in recommendation and receipt of medications and 
vaccinations, there were also some major differences in visit documentation among the PTC and 
PCP groups. The pharmacist providers in the PTC group documented purpose of travel more 
frequently than the PCPs (99% vs. 55%, P < 0.0001) and also documented activities planned by 
the traveler more frequently (70% vs. 48%, P < 0.0001) than the PCPs. 
 There were no statistically significant differences between the two patient populations 
except for destination and purpose of travel. The PTC saw more travelers to North Africa and 
also more travelers with volunteer work as their purpose. The PCPs saw more travelers to North 
and Southeast Asia and also more travelers with study abroad as their purpose. (Table 1).  
Gender, age, and duration of travel were similar between the two groups. 
 The two categorical variables that demonstrated a clear statistically significant difference 
in the multivariate analyses were visit type (PTC vs. PCP) and destination (travel to Southeast 
Asia vs. others). When indicated, patients in the PTC and those seen by the PCP who were 
traveling to Southeast Asia were more likely to be ordered the oral Typhoid vaccine (P = 0.0380, 
OR = 1.743, 95% CI 1.031-2.945) and Tdap (P = 0.0045, OR = 2.204, 95% CI 1.277-3.802) 
compared to other destinations. However, when indicated travelers who had a visit with a PCP 
were less likely to be ordered the oral Typhoid vaccine (P = 0.0004, OR = 0.369, 95% CI 0.211-
0.643) and Tdap (P < 0.0001, OR = 0.224, 95% CI 0.127-0.395) compared to travelers who 
visited the PTC. Trip duration and purpose of travel (volunteer and study abroad) did not have a 
significant effect on whether or not the oral Typhoid vaccine and Tdap were ordered when 
indicated. When ordered, travelers to Southeast Asia were also more likely to pick-up from the 
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pharmacy azithromycin (P < 0.0001, OR = 7.375, 95% CI 3.353-16.22), atovaquone-proguanil 
(P < 0.0024, OR = 2.33, 95% CI 1.351-4.02), oral Typhoid vaccine (P = 0.0398, OR = 1.749, 
95% CI 1.027-2.981), and to receive Tdap vaccination (P = 0.0045, OR = 2.204, CI 1.277-
3.802). 
Discussion 
 The results of this study support previous publications illustrating that recommendation 
of medications and vaccines not consistent with guidelines is a potential problem for PCPs 
without special training, demonstrating a need for additional education and training. 13, 18-19, 21-22 
The most common area in which the PCPs failed to follow national/international guidelines was 
in the omission of recommended antibiotics for the self-treatment of travelers’ diarrhea. The 
PCPs only ordered an antibiotic for traveler’s diarrhea for half of the patients who were indicated 
and less of their patients picked it from the pharmacy compared to the pharmacists. Since the 
PTC visits are consistently structured to include extensive counseling on food/water precautions 
and food/water borne illnesses, this may help explain why higher antibiotic pick-up rates 
occurred among the PTC group. In both groups, pick-up rates for antibiotics were lower than for 
antimalarials, suggesting that the study population may perceive food and water borne illnesses 
as less serious than malaria. 
 Omission of recommendations for antimalarials and vaccines when indicated was also 
common among PCPs. Purpose of travel and activities planned were only documented in half of 
the PCP visits, suggesting that the providers either do not take these variables into consideration 
or simply do not routinely document these patient specific factors. Practice guidelines suggest 
taking into account these itinerary variables impacts the assessment of each patient’s indication 
for medications and vaccines, and thus this may have affected PCP recommendations. 
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 The use of medications for travel to destinations where antimicrobial resistance exists, 
such as ciprofloxacin for travelers’ diarrhea in Thailand or chloroquine for malaria 
chemoprophylaxis in Africa, was another area where the PTC consistently showed higher 
compliance with the national/international travel guidelines.  Other areas of inconsistency 
between PCP and PTC involved recommendations of vaccines for diseases where no risk exists, 
such as Yellow Fever vaccine for a traveler to Southeast Asia. 
 The observations that the PTC saw more travelers with volunteer work as their primary 
purpose and the PCPs saw more travelers with school as there primary purpose was expected.  
The pharmacist-run travel clinic frequently conducts group consultations, which can be more 
convenient for large, organized volunteer groups.  Many study abroad programs require a 
medical exam and clearance prior to a student enrolling, which would necessitate a traveler to 
have a visit with a PCP.  Since visits with the PTC and PCP were equal in length, vaccines were 
administered in the same clinic, and medications were dispensed from the same pharmacy, these 
factors should not have influenced outcomes. The PCPs generally had family medicine or 
internal medicine training background and did receive a 1 hour travel medicine update every year 
as part of a health center grand rounds program.   
 While previous studies of international community pharmacists have not been positive 
toward their travel medicine knowledge, no such study has been conducted in the United States, 
where all schools of pharmacy confer only the Doctor of Pharmacy degree after 6 to 8 years of 
training and many graduates pursue post-graduate residencies.  With the launch of the 
Pharmacists Professional Group within the ISTM and more pharmacists sitting for the ISTM 
CTH® exam, there are likely to be more trained and credentialed pharmacists to serve the 
traveling public. 
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Limitations 
A limitation of the study is that the patient population consisted of young college students 
and may not represent the general population. However, their destinations and itineraries mirror 
populations in other reports.  Additionally, appropriate use of vaccines and medications could 
only be determined by the amount of information provided in the progress note; therefore, if a 
recommendation was not documented it was assumed that it did not occur.  Lastly, due to the 
retrospective nature of the study, differences in post graduate training of the PCPs and the 
volume of patients they saw could not be controlled. 
Conclusion 
 
A pharmacist-run pre-travel health clinic can provide more consistent evidence-based 
care compared to primary care practitioners not specifically trained in travel medicine and may 
improve patient compliance with recommendations.  Pre-travel health is a dynamic and 
specialized field that requires adequate time, resources, and expertise to deliver the best possible 
care. 
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Table 1: Traveler Characteristics 
                PTC (N=341)        PCP (N=172) 
Gender 
Male 124 (36.36%) 61 (35.47%) 
Female 217 (63.64%) 111 (65.53%) 
Age 
18-25 259 (75.95%) 124 (72.09%) 
26-35 80 (23.46%) 45 (26.16%) 
36-45 1 (0.29%) 2 (1.16%) 
46-55 1 (0.29%) 0 
>55 0 1 (0.58%) 
Duration of Travel¥ 
<1 week 53 (16.06%) 15 (9.87%) 
>1, <2 weeks 104 (31.52%) 53 (34.87%) 
>2, <4 weeks 64 (19.39%) 26 (17.11%) 
>4, <12 weeks 57 (17.27%) 27 (17.76%) 
> 12 weeks 52 (15.76%) 31 (20.39%) 
Destinations+ 
Central America/Mexico/Caribbean 148 (43.53%) 60 (34.88%) 
South America 40 (11.76%) 18 (10.47%) 
North Africa* (P = 0.0418) 13 (3.82%) 1 (0.58%) 
Sub-Saharan Africa 60 (17.65%) 24 (13.95%) 
Middle East (Western Asia) 3 (0.88%) 4 (2.33%) 
Western Europe 21 (6.18%) 11 (6.40%) 
Eastern Europe 9 (2.65%) 6 (3.49%) 
South Central Asia 28 (8.24%) 11 (6.40%) 
Southeast & North Asia* (P = 0.0063) 73 (21.47%) 56 (32.56%) 
Australia & New Zealand 2 (0.59%) 2 (1.16%) 
Purpose of Travel¥ + 
School* (P < 0.0001) 85 (25.30%) 51 (54.84%) 
Business 79 (23.51%) 22 (24.18%) 
Pleasure 10 (2.98%) 1 (1.11%) 
Volunteer* (P < 0.0001) 161 (47.92%) 20 (22.47%) 
* = Statistically Significant, + = Values do not add up to 100%, ¥ = Missing Data 
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Table 2: Order and Receipt of Medications 
 PTC (N=341) PCP (N=172) P-Value* 
Antibiotics  
Ordered when indicated 327 (96.18%) 85 (50.30%) <0.0001 
Received when ordered# 244 (74.62%) 51 (62.96%) 0.0359 
Not Consistent with Guidelines 
Not ordered when indicated 21 (6.16%) 84 (48.84%) <0.0001 
Ordered when not indicated 11 (3.25%) 22 (20.56%) <0.0001 
Antimalarials  
Ordered when indicated 220 (97.78%) 111 (81.02%) <0.0001 
Received when ordered# 176 (81.48%) 95 (86.36%) 0.2657 
Not Consistent with Guidelines 
Not ordered when indicated 5 (1.47%) 26 (15.12%) <0.0001 
Ordered when not indicated 5 (2.22%) 26 (18.98%) <0.0001 
# Medications documented as refused/declined were excluded from the analyses of receipt rates 
* Chi-square test (or Fisher’s exact test) at 0.05 α level 
Table 3: Order and Receipt of Vaccinations 
Number of Vaccines Per 
Patient 
PTC (N=341) PCP (N=172) 
P-Value* 
Mean Median std Mean Median std 
Ordered when indicated 2.78 3.00 1.49 2.06 2.00 1.34 <0.0001 
Received when ordered# 2.38 2.00 1.54 1.95 2.00 1.34 0.0039 
Not Consistent with Guidelines 
Not ordered when indicated 0.12 0 0.37 0.78 0 1.00 <0.0001 
Ordered when not indicated 0.035 0 0.2 0.18 0 0.49 <0.0001 
# Vaccinations documented as refused/declined were excluded from the analyses of receipt rates 
* Wilcoxon-Mann-Whitney Test (Non-parametric version of independent samples T-test) at 0.05 
α level 
 
